Xenetic Biosciences, Inc. financial data

Symbol
XBIO on Nasdaq
Location
945 Concord St., Framingham, MA
State of incorporation
NV
Fiscal year end
December 31
Former names
General Sales & Leasing, Inc. (to 1/10/2014), GENERAL AIRCRAFT INC. (to 2/12/2013)
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 713 % -43.8%
Debt-to-equity 14.4 % +81.8%
Return On Equity -54.3 % -49.2%
Return On Assets -47.5 % -40.7%
Operating Margin -168 % +5.42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.54M shares +0.09%
Common Stock, Shares, Outstanding 1.54M shares +0.09%
Entity Public Float 5.3M USD +5.47%
Common Stock, Value, Issued 1.55K USD +0.07%
Weighted Average Number of Shares Outstanding, Basic 1.54M shares +0.86%
Weighted Average Number of Shares Outstanding, Diluted 1.54M shares +0.86%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.5M USD -1.56%
Research and Development Expense 3.29M USD -5.91%
General and Administrative Expense 3.42M USD -4.06%
Operating Income (Loss) -4.2M USD +6.89%
Nonoperating Income (Expense) 244K USD -35.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.96M USD +4.22%
Earnings Per Share, Basic -2.57 USD/shares +5.17%
Earnings Per Share, Diluted -2.57 USD/shares +5.17%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 6.59M USD -31.3%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 314K USD -69.2%
Assets 6.9M USD -34.9%
Accounts Payable, Current 284K USD +17.8%
Employee-related Liabilities, Current 243K USD +12.4%
Accrued Liabilities, Current 611K USD +7.37%
Liabilities, Current 894K USD +10.5%
Liabilities 894K USD +10.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 254K USD 0%
Retained Earnings (Accumulated Deficit) -197M USD -2.05%
Stockholders' Equity Attributable to Parent 6.01M USD -38.7%
Liabilities and Equity 6.9M USD -34.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.16M USD -5.16%
Common Stock, Shares Authorized 10M shares 0%
Common Stock, Shares, Issued 1.54M shares +0.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.17M USD -31.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 41.1M USD +3.58%
Deferred Tax Assets, Gross 41.1M USD +3.58%
Operating Lease, Liability, Current 0 USD -100%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 208M USD +0.08%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 300K USD -40%